{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:37:18Z","timestamp":1772645838965,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11899-022-00686-0","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T07:17:14Z","timestamp":1676618234000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income Countries"],"prefix":"10.1007","volume":"18","author":[{"given":"Mika","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Annamalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald","family":"Radich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"686_CR1","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","volume":"34","author":"H Bower","year":"2016","unstructured":"Bower H, Bj\u00f6rkholm M, Dickman PW, H\u00f6glund M, Lambert PC, Andersson TM-L. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol. 2016;34:2851\u20137. https:\/\/doi.org\/10.1200\/JCO.2015.66.2866. Analysis of Swedish Cancer Registry in 1973\u20132013 demonstrating advancement in treatment options for CML has improved the life expectancy of patients with CML to a similar level in the general population.","journal-title":"J Clin Oncol"},{"key":"686_CR2","doi-asserted-by":"publisher","unstructured":"Malhotra H, Radich J, Garcia-Gonzalez P. Meeting the needs of CML patients in resource-poor countries. Hematology 2014, the American Society of Hematology Education Program Book. 2019;2019(1):433\u201342. https:\/\/doi.org\/10.1182\/hematology.2019000050.\u00a0A great overview of the myriad challenges and solutions of diagnosing and treating CML in low- and-middle income coutries.","DOI":"10.1182\/hematology.2019000050"},{"key":"686_CR3","doi-asserted-by":"publisher","unstructured":"Garcia-Gonzalez P, Boultbee P, Epstein D. Novel humanitarian aid program: the glivec international patient assistance program-lessons learned from providing access to breakthrough targeted oncology treatment in low- and middle-income countries. J Glob Oncol. 2015;1(1):37\u201345. https:\/\/doi.org\/10.1200\/JGO.2015.000570.\u00a0The article describes the structure of the GIPAP program and lessons that have contributed to the success of the program.","DOI":"10.1200\/JGO.2015.000570"},{"key":"686_CR4","unstructured":"The Max Foundation. Patient Access Tracking System. [cited 6 Jun 2022]. Available: https:\/\/www.maxaid.org\/"},{"key":"686_CR5","doi-asserted-by":"publisher","first-page":"e0239797","DOI":"10.1371\/journal.pone.0239797","volume":"15","author":"N Bottan","year":"2020","unstructured":"Bottan N, Hoffmann B, Vera-Cossio D. The unequal impact of the coronavirus pandemic: evidence from seventeen developing countries. PLoS ONE. 2020;15:e0239797. https:\/\/doi.org\/10.1371\/journal.pone.0239797.","journal-title":"PLoS ONE"},{"key":"686_CR6","doi-asserted-by":"publisher","first-page":"e008477","DOI":"10.1136\/bmjgh-2022-008477","volume":"7","author":"AT Levin","year":"2022","unstructured":"Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Glob Health. 2022;7:e008477. https:\/\/doi.org\/10.1136\/bmjgh-2022-008477. Systematic review of serology studies showing higher burden of COVID-19 in LMICs towards the beginning of the pandemic due to challenges such as lack of access to health care.","journal-title":"BMJ Glob Health"},{"key":"686_CR7","doi-asserted-by":"publisher","first-page":"010367","DOI":"10.7189\/jogh.10.010367","volume":"10","author":"D Kumar","year":"2020","unstructured":"Kumar D, Dey T. Treatment delays in oncology patients during COVID-19 pandemic: a perspective. J Glob Health. 2020;10:010367. https:\/\/doi.org\/10.7189\/jogh.10.010367.","journal-title":"J Glob Health"},{"key":"686_CR8","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1373\/clinchem.2007.085472","volume":"53","author":"ES Winn-Deen","year":"2007","unstructured":"Winn-Deen ES, Helton B, Van Atta R, Wong W, Peralta J, Wang J, et al. Development of an integrated assay for detection of BCR-ABL RNA. Clin Chem. 2007;53:1593\u2013600. https:\/\/doi.org\/10.1373\/clinchem.2007.085472.","journal-title":"Clin Chem"},{"key":"686_CR9","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2015-12-689059","volume":"127","author":"O Sala Torra","year":"2016","unstructured":"Sala Torra O, Beppu L, Smith JL, Welden L, Georgievski J, Gupta K, et al. Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots. Blood. 2016;127:2773\u20134. https:\/\/doi.org\/10.1182\/blood-2015-12-689059. First example of using dried blood spots for BCR-ABL1 mRNA testing.","journal-title":"Blood"},{"key":"686_CR10","first-page":"1719","volume":"21","author":"R Sooknanan","year":"1993","unstructured":"Sooknanan R, Malek L, Wang XH, Siebert T, Keating A. Detection and direct sequence identification of BCR-ABL mRNA in Ph+ chronic myeloid leukemia. Exp Hematol. 1993;21:1719\u201324.","journal-title":"Exp Hematol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-022-00686-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-022-00686-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-022-00686-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T06:27:10Z","timestamp":1677652030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-022-00686-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1007\/s11899-022-00686-0","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"5 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Annamalay reports grants from Novartis,grants from Bristol Myers Squibb, grants from Pfizer, grants from Takeda, and grants from Incyte, during the conduct of the study, and grants from Novartis, grants from Bristol Myers Squibb, grants from Pfizer, grants from Takeda, and grants from Incyte, outside the submitted work.Dr. Radich reports other from Cepheid, outside the submitted work.Dr. Matsuzaki\u2019s contribution to this publication was as a member of the Board of Directors of The Max Foundation. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}